Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients

The detection of RAS mutations and co-mutations in liquid biopsy offers a novel paradigm for the dynamic management of metastatic colorectal cancer (mCRC) patients. Expanding the results of the prospective OMITERC (OMIcs application from solid to liquid biopsy for a personalized ThERapy of Cancer) p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavacchi, Daniele, Gelmini, Stefania, Calabri, Adele, Rossi, Gemma, Simi, Lisa, Caliman, Enrico, Mancini, Irene, Salvianti, Francesca, Petroni, Giulia, Guidolin, Alessia, Scolari, Federico, Messerini, Luca, Pillozzi, Serena, Pinzani, Pamela, Antonuzzo, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663919/
https://www.ncbi.nlm.nih.gov/pubmed/38027900
http://dx.doi.org/10.1016/j.heliyon.2023.e21853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663919/
https://www.ncbi.nlm.nih.gov/pubmed/38027900
http://dx.doi.org/10.1016/j.heliyon.2023.e21853

Ejemplares similares